Earnings Outlook For Spero Therapeutics
Portfolio Pulse from Benzinga Insights
Spero Therapeutics (NASDAQ:SPRO) is scheduled to release its quarterly earnings report on March 13, 2024, with an expected EPS of $-0.10. Historical data shows a correlation between earnings performance and stock price movement. Last quarter, SPRO missed its EPS estimate by $0.03, leading to a 1.8% drop in its share price. Over the last year, SPRO shares have increased by 15.99%, indicating a positive outlook from long-term shareholders.
March 12, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Spero Therapeutics is expected to report an EPS of $-0.10 for the upcoming quarter. Historical performance indicates potential stock price movement post-earnings announcement.
Given Spero Therapeutics' history of stock price movement following earnings reports, the upcoming announcement could lead to short-term volatility. However, the overall positive yearly performance and anticipation of future guidance make the short-term impact uncertain.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100